P, D., MT, M., J, C., TJ, D., R, E., BL, L., . . . SB, W. (2016). Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy, 36(2), 203. https://doi.org/10.1002/phar.1700
Chicago Style (17th ed.) CitationP, Deming, et al. "Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists." Pharmacotherapy 36, no. 2 (2016): 203. https://doi.org/10.1002/phar.1700.
MLA (9th ed.) CitationP, Deming, et al. "Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists." Pharmacotherapy, vol. 36, no. 2, 2016, p. 203, https://doi.org/10.1002/phar.1700.
Warning: These citations may not always be 100% accurate.